Investigative Uricosuric Compound Lowers Serum Uric Acid in Patients With Gout ... - DG News

Investigative Uricosuric Compound Lowers Serum Uric Acid in Patients With Gout ... DG News "The results of this trial demonstrate that RDEA594 is a promising new drug for the treatment of hyperuricaemia in gout patients and support the initiation ... Study Confirms Febuxostat Utility in Reducing Serum Uric Acid to Goal Among ...DG News EULAR: Meta-Analysis Confirms Febuxostat Utility in Gout PatientsMedPage Today all 3 news articles »

Regeneron gout drug works in one trial, fails other - Reuters

Regeneron gout drug works in one trial, fails other Reuters VX) is also developing a treatment for gout. Shares of Regeneron were down 3 percent at .83 in afternoon trade on Nasdaq. They touched a low of .32 ... Regeneron gout drug meets study goalsBusinessWeek The Drug Passed, but the Stock Fell?Motley Fool All About Gout: Arcalyst Meets Phase III Prophylaxis EndpointBioWorld Online Wall Street Journal -Monthly Prescribing Reference -PR Newswire (press release) all 74 news articles »

EULAR: Canakinumab Prevents Flares in Gout Patients - MedPage Today

EULAR: Canakinumab Prevents Flares in Gout Patients MedPage Today Canakinumab is still an experimental treatment for gout and is available only through clinical trials. ... EULAR: Experimental Compound Helps Gout Patients, Lowers Uric AcidMedPage Today EULAR: Febuxostat Bests Allopurinol in GoutMedPage Today all 8 news articles »

EULAR: Models Look at Costs of Gout Treatment - MedPage Today

EULAR: Models Look at Costs of Gout Treatment MedPage Today "Allopurinol has been the standard pharmaceutical treatment for gout for over 40 years," Meltzer told MedPage Today at her poster presentation. ... Febuxostat Appears to Outperform Allopurinol in Percentage of Gout Patients ...DG News EULAR: Gout Not 'Cured' Until Crystals DropMedPage Today all 5 news articles »